Alois Saria

Alois Saria's AcademicInfluence.com Rankings

Alois Saria

Biology

#9457

World Rank

#12668

Historical Rank

Neuroscience

#1385

World Rank

#1432

Historical Rank

biology Degrees

Download Badge

Biology

Alois Saria's Degrees

Doctorate Medicine Medical University of Innsbruck
PhD Pharmacology Medical University of Innsbruck

Why Is Alois Saria Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Alois Saria's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017 (2017) (714)
Capsaicin-induced desensitization of airway mucosa to cigarette smoke, mechanical and chemical irritants (1983) (485)
A substance P antagonist inhibits vagally induced increase in vascular permeability and bronchial smooth muscle contraction in the guinea pig. (1983) (423)
Evans blue fluorescence: quantitative and morphological evaluation of vascular permeability in animal tissues (1983) (423)
Release of multiple tachykinins from capsaicin-sensitive sensory nerves in the lung by bradykinin, histamine, dimethylphenyl piperazinium, and vagal nerve stimulation. (1988) (405)
Potentiation of tachykinin-induced plasma protein extravasation by calcitonin gene-related peptide. (1985) (332)
Effects and distribution of vagal capsaicin-sensitive substance P neurons with special reference to the trachea and lungs. (1983) (284)
Induction of tachykinin gene and peptide expression in guinea pig nodose primary afferent neurons by allergic airway inflammation. (1996) (283)
Substance P and capsaicin-induced contraction of human bronchi. (1983) (243)
Polypeptide-containing neurons in airway smooth muscle. (1987) (230)
Vascular permeability changes and smooth muscle contraction in relation to capsaicin-sensitive substance P afferents in the guinea-pig. (1984) (228)
The tachykinin NK1 receptor in the brain: pharmacology and putative functions. (1999) (203)
Simultaneous release of several tachykinins and calcitonin gene-related peptide from rat spinal cord slices (1986) (198)
Substance P in the medial amygdala: Emotional stress-sensitive release and modulation of anxiety-related behavior in rats (2004) (196)
Substance P-immunoreactive sensory nerves in the lower respiratory tract of various mammals including man (2004) (190)
Capsaicin-sensitive vagal neurons involved in control of vascular permeability in rat trachea. (1982) (190)
Bronchial smooth muscle contraction induced by stimulation of capsaicin-sensitive sensory neurons. (1982) (188)
Mechanisms underlying pre- and postjunctional effects of neuropeptide Y in sympathetic vascular control. (1986) (166)
Sensory neurons mediate protective vasodilatation in rat gastric mucosa. (1991) (162)
Involvement of 5-hydroxytryptamine, prostaglandin E2, and cyclic adenosine monophosphate in cholera toxin-induced fluid secretion in the small intestine of the rat in vivo. (1989) (159)
Calcitonin gene-related peptide and the lung: neuronal coexistence with substance P, release by capsaicin and vasodilatory effect (1988) (153)
Secretoneurin releases dopamine from rat striatal slices: A biological effect of a peptide derived from secretogranin II (chromogranin C) (1993) (149)
Introducing the Human Brain Project (2011) (146)
Influence of patient-related variables on clozapine plasma levels. (1990) (139)
Vascular protein leakage in various tissues induced by substance P, capsaicin, bradykinin, serotonin, histamine and by antigen challenge (1983) (139)
Differential release of calcitonin gene-related peptide and neuropeptide Y from the isolated heart by capsaicin, ischaemia, nicotine, bradykinin and ouabain. (1989) (138)
Capsaicin induced release of multiple tachykinins (substance P, neurokinin A and eledoisin-like material) from guinea-pig spinal cord and ureter (1986) (137)
Explaining the Escalation of Drug Use in Substance Dependence: Models and Appropriate Animal Laboratory Tests (2007) (123)
Neuropeptide Y receptor in pig spleen: binding characteristics, reduction of cyclic AMP formation and calcium antagonist inhibition of vasoconstriction. (1988) (120)
Increased vascular permeability in rat nasal mucosa induced by substance P and stimulation of capsaicin-sensitive trigeminal neurons. (1983) (120)
Substance P in sensory nerve fibres contributes to the development of oedema in the rat hind paw after thermal injury (1984) (119)
Clozapine concentrations in maternal and fetal plasma, amniotic fluid, and breast milk. (1994) (116)
Distribution of secretoneurin, a peptide derived from secretogranin II, in rat brain: An immunocytochemical and radioimmunological study (1993) (115)
Reversal of cocaine‐conditioned place preference and mesocorticolimbic Zif268 expression by social interaction in rats (2011) (112)
Cigarette smoke-induced airway oedema due to activation of capsaicin-sensitive vagal afferents and substance P release (1983) (101)
Nociceptive behavior after intrathecal injections of substance P, neurokinin A and calcitonin gene-related peptide in mice (1986) (99)
Release of substance P- and substance K-like immunoreactivities from the isolated perfused guinea-pig lung. (1984) (98)
Ketamine-Induced Modulation of the Thalamo-Cortical Network in Healthy Volunteers As a Model for Schizophrenia (2015) (97)
Neuropeptide Y (NPY) and peptide YY (PYY) inhibit prostaglandin E2-induced intestinal fluid and electrolyte secretion in the rat jejunum in vivo. (1985) (94)
Dose-related plasma levels of clozapine: influence of smoking behaviour, sex and age (2004) (92)
Distribution of capsaicin in rat tissues after systemic administration (1982) (92)
Secretoneurin: a new player in angiogenesis and chemotaxis linking nerves, blood vessels and the immune system. (2005) (91)
Influence of age, gender, body weight and valproate comedication on quetiapine plasma concentrations (2006) (89)
Reinforcing Effects of MDMA (‘Ecstasy’) in Drug-Naive and Cocaine-Trained Rats (2001) (87)
TDM in psychiatry and neurology: A comprehensive summary of the consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology, update 2017; a tool for clinicians* (2018) (85)
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017 (2018) (83)
Capsaicin-induced substance P release and sensory control of vascular permeability in the guinea-pig ureter (1983) (81)
Clozapine-induced transient white blood count disorders. (1994) (81)
Several mediators appear to interact in neurogenic inflammation. (1987) (79)
Autonomic mechanisms underlying capsaicin induced oral sensations and salivation in man. (1986) (78)
Human and Rat Primary C‐Fibre Afferents Store and Release Secretoneurin, a Novel Neuropeptide (1994) (77)
Evidence for specific neuropeptide Y-binding sites in rat brain synaptosomes. (1984) (75)
Activation of Muscarinic and Nicotinic Acetylcholine Receptors in the Nucleus Accumbens Core Is Necessary for the Acquisition of Drug Reinforcement (2006) (73)
Substance P in the adrenal gland: Origin and species distribution (1981) (73)
Plasma CGRP in acute myocardial infarction (1990) (73)
Calcitonin gene-related peptide: release by capsaicin and prolongation of the action potential in the guinea-pig heart. (1988) (72)
Conditioned place preference for social interaction in rats: contribution of sensory components (2011) (71)
Coexistence of multiple peptides and classic transmitters in airway neurons: functional and pathophysiologic aspects. (1987) (71)
Effects of Age and Sex on Olanzapine Plasma Concentrations (2005) (69)
Determination of capsaicin in tissues and separation of capsaicin analogues by high-performance liquid chromatography. (1981) (66)
EEG alterations in patients treated with clozapine in relation to plasma levels (1992) (66)
A study of the concentrations of substance p and neurotensin in the gastrointestinal tract of various mammals (1982) (65)
Therapeutic monitoring of aripiprazole by HPLC with column-switching and spectrophotometric detection. (2005) (64)
Neuropeptide y- and alpha-adrenergic receptors in pig spleen: Localization, binding characteristics, cyclic amp effects and functional responses in control and denervated animals (1988) (60)
5-HT3 receptor antagonists inhibit sensory neuropeptide release from the rat spinal cord. (1990) (59)
Evidence for substance P-immunoreactive spinal afferents that mediate bronchoconstriction. (1985) (57)
Neuropeptide Levels after Pentylenetetrazol Kindling in the Rat (1990) (56)
Distribution and origin of substance P and neuropeptide Y-immunoreactive nerves in the guinea-pig heart (2004) (56)
Neuropeptide Y inhibits excitatory enteric neurons supplying the circular muscle of the guinea pig small intestine. (1987) (55)
MDMA (‘ecstasy’) enhances basal acetylcholine release in brain slices of the rat striatum (2000) (55)
Distribution of Secretoneurin‐like Immunoreactivity in Comparison with Substance P‐ and Enkephalin‐like Immunoreactivities in Various Human Forebrain Regions (1993) (55)
Differential Effects of Accumbens Core vs. Shell Lesions in a Rat Concurrent Conditioned Place Preference Paradigm for Cocaine vs. Social Interaction (2011) (53)
Antidromic vasodilatation in the rat hindpaw measured by laser Doppler flowmetry: pharmacological modulation. (1987) (51)
Do vertical shifts in dose-response rate-relationships in operant conditioning procedures indicate “sensitization” to “drug wanting”? (2004) (50)
Opioid-related changes in nociceptive threshold and in tissue levels of enkephalins after target disruption of the gene for neutral endopeptidase (EC 3.4.24.11) in mice (1997) (50)
Mechanisms underlying changes in the contents of neuropeptide Y in cardiovascular nerves and adrenal gland induced by sympatholytic drugs. (1985) (49)
Stimulation of rat adrenal medulla can induce differential changes in the peptide and mRNA levels of chromogranins, neuropeptides and other constituents of chromaffin granules (1991) (49)
Intravenous administration of ecstasy (3,4-methylendioxymethamphetamine) enhances cortical and striatal acetylcholine release in vivo. (2001) (49)
Dopamine neurons in a simple GDNF-treated meso-striatal organotypic co-culture model (1999) (48)
Handbook of Alcoholism (2000) (48)
Histamine in tissue: determination by high-performance liquid chromatography after condensation with o-phthaldialdehyde. (1981) (48)
Simultaneous Determination of Paroxetine, Risperidone and 9-Hydroxyrisperidone in Human Plasma by High-Performance Liquid Chromatography with Coulometric Detection (2000) (47)
St. John's wort (Hypericum perforatum) and breastfeeding: plasma and breast milk concentrations of hyperforin for 5 mothers and 2 infants. (2006) (47)
Molecular characterization of immunoreactivities of peptides derived from chromogranin a (GE-25) and from secretogranin II (secretoneurin) in human and bovine cerebrospinal fluid (1994) (46)
Substance P and opiate-like peptides in human adrenal medulla (1980) (46)
Calcitonin gene-related peptide in patients with and without early reperfusion after acute myocardial infarction. (1992) (45)
Videotape preparation of patients before hip replacement surgery reduces stress. (1998) (45)
Insulin hypoglycemia increases the levels of neuropeptide Y and calcitonin gene-related peptide, but not of chromogranins A and B, in rat chromaffin granules (1989) (45)
Comparative distribution of neurokinin B-, substance P- and enkephalin-like immunoreactivities and neurokinin B messenger RNA in the basal forebrain of the rat: Evidence for neurochemical compartmentation (1992) (45)
Neuropeptide Y and noradrenaline interaction in peripheral cardiovascular control. (1984) (44)
Brain regions associated with the acquisition of conditioned place preference for cocaine vs. social interaction (2012) (43)
Injection of tachykinins and selective neurokinin receptor ligands into the substantia nigra reticulata increases striatal dopamine and 5-hydroxytryptamine metabolism. (1991) (43)
Glial-cell-line-derived neurotrophic factor enhances biosynthesis of substance P in striatal neurons in vitro (1996) (42)
CSF of neuroleptic-naive first-episode schizophrenic patients: Levels of biogenic amines, substance P, and peptides derived from chromogranin A (GE-25) and secretogranin II (secretoneurin) (1996) (42)
Activation of PKCzeta and PKMzeta in the Nucleus Accumbens Core Is Necessary for the Retrieval, Consolidation and Reconsolidation of Drug Memory (2012) (41)
A randomized trial of short psychotherapy versus sustained-release bupropion for smoking cessation. (2008) (41)
Characterization of substance P-like immunoreactivity in submammalian species by high performance liquid chromatography (1985) (40)
Release of histamine by substance P (1981) (40)
Intravenous Drug Injection Habits: Drug Users’ Self-Reports versus Researchers’ Perception (2003) (40)
Differential effects of reserpine and 6-hydroxydopamine on neuropeptide Y (NPY) and noradrenaline in peripheral neurons (2004) (39)
Lschaemia and changes in contractility induce release of calcitonin gene-related peptide but not neuropeptide Y from the isolated perfused guineapig heart (1987) (38)
Preventive role of social interaction for cocaine conditioned place preference: correlation with FosB/DeltaFosB and pCREB expression in rat mesocorticolimbic areas (2012) (38)
Levels and proteolytic processing of chromogranin A and B and secretogranin II in cerebrospinal fluid in neurological diseases (1998) (37)
Long-term pharmacokinetics of clozapine (1998) (36)
Neuropeptides in human salivary (submandibular and parotid) glands. (1992) (36)
Increase in tissue concentrations of histamine and 5-hydroxytryptamine following capsaicin treatment of newborn rats. (1981) (35)
Regulatory peptides and general neuroendocrine markers in human nasal mucosa, soft palate and larynx. (1991) (34)
Effects of secretogranin II-derived peptides on the release of neurotransmitters monitored in the basal ganglia of the rat with in vivo microdialysis (1996) (34)
Autonomic and peptidergic innervation of human nasal mucosa. (1993) (34)
Substance P in primary afferent neurons of the female rat reproductive system (1984) (33)
Acute and chronic noradrenergic regulation of neurotrophin messenger RNA expression in rat hippocampus: Evidence from lesions and organotypic cultures (1996) (33)
Escitalopram plasma levels and antidepressant response (2017) (33)
The effects of neonatal capsaicin treatment on growth and subsequent reproductive function in the rat (1984) (32)
Distribution of secretoneurin immunoreactivity in the spinal cord and lower brainstem in comparison with that of substance P and calcitonin gene‐related peptide (1994) (32)
Clozapine plasma levels determined by high-performance liquid chromatography with ultraviolet detection. (1988) (31)
Sigma1 Receptor Antagonist BD1047 Enhances Reversal of Conditioned Place Preference from Cocaine to Social Interaction (2010) (30)
Neuropeptide chronomics in clinically healthy young adults: circaoctohoran and circadian patterns (2004) (30)
Pharmacokinetics and elimination of quetiapine, venlafaxine, and trazodone during pregnancy and postpartum. (2007) (30)
Neuropeptide Y and non-adrenergic sympathetic vascular control of the cat nasal mucosa. (1987) (30)
Presence and distribution of a new neuropeptide, secretoneurin, in human retina (1996) (30)
Pronounced increases in brain levels of calcitonin gene-related peptide after kainic acid induced seizures (1989) (29)
Secretoneurin promotes pertussis toxin‐sensitive neurite outgrowth in cerebellar granule cells (2003) (29)
Subjective Effects of Slow-Release Bupropion versus Caffeine as Determined in a Quasi-Naturalistic Setting (2004) (29)
Differential changes in tachykinins after kainic acid-induced seizures in the rat (1990) (29)
Dose-related plasma levels of clozapine. (1989) (28)
Intranigral injection of selective neurokinin-1 and neurokinin-3 but not neurokinin-2 receptor agonists biphasically modulate striatal dopamine metabolism but not striatal preprotachykinin-A mRNA in the rat (1993) (28)
Neurokinin A depolarizes neurons of the guinea pig inferior mesenteric ganglia (1985) (28)
Whole-exome sequencing identifies a polymorphism in the BMP5 gene associated with SSRI treatment response in major depression (2013) (28)
Reserpine-induced depletion of neuropeptide Y in the guinea-pig: tissue-specific effects and mechanisms of action. (1987) (27)
Reacquisition of cocaine conditioned place preference and its inhibition by previous social interaction: Neurochemical and electrophysiological correlates in the nucleus accumbens corridor (2015) (27)
Alterations within the endogenous opioid system in mice with targeted deletion of the neutral endopeptidase (‘enkephalinase’) gene (2000) (27)
The substance P (NK1) receptor antagonist (±)-CP-96,345 causes sedation and motor impairment in Swiss albino mice in the black-and-white box behavioral paradigm (1992) (27)
A substance P antagonist inhibits heat-induced oedema in the rat skin. (1984) (27)
Capsaicin pretreatment abolishes cigarette smoke-induced oedema in rat tracheo-bronchial mucosa. (1982) (26)
Nucleus Accumbens Core Acetylcholine is Preferentially Activated During Acquisition of Drug- vs Food-Reinforced Behavior (2008) (25)
Neurokinin a in capsaicin-sensitive neurons of the guinea-pig inferior mesenteric ganglia: An additional putative mediator for the non-cholinergic excitatory postsynaptic potential (1987) (24)
Opioids, cocaine, and food change runtime distribution in a rat runway procedure (2003) (23)
Thiorphan, a neutral endopeptidase inhibitor used for diarrhoea, is neuroprotective in newborn mice. (2006) (23)
Neutral endopeptidase knockout induces hyperalgesia in a model of visceral pain, an effect related to bradykinin and nitric oxide (2002) (23)
Secretoneurin-like immunoreactivity in rat sympathetic, enteric and sensory ganglia (1997) (23)
Methylenedioxymethamphetamine (MDMA, ‘Ecstasy‘) Serves as a Robust Positive Reinforcer in a Rat Runway Procedure (2003) (22)
Inhibition of compound 48/80 — induced vascular protein leakage by pretreatment with capsaicin and a substance P antagonist (1984) (22)
Simultaneous intra-accumbens remifentanil and dopamine kinetics suggest that neither determines within-session operant responding (2005) (22)
Distribution of secretoneurin-like immunoreactivity in comparison with that of substance P in the human brain stem (1994) (22)
Substance P in tumors: Pheochromocytoma and carcinoid (1981) (21)
Rapid and sensitive determination of clozapine in human plasma using high-performance liquid chromatography and amperometric detection. (1989) (21)
Signal transduction efficacy of the highly potent mu opioid agonist 14-methoxymetopon. (2000) (21)
Calcitonin gene‐related peptide in the amygdaloid complex of the rat: Immunohistochemical and quantitative distribution, and drug effects on calcium dependent, potassium‐evoked in vitro release (1991) (21)
Selective vulnerability of cerebellar granule neuroblasts and their progeny to drugs with abuse liability (2003) (21)
Characterization of neurokinin binding sites in rat brain membranes using highly selective ligands (1993) (20)
Effects of the bradykinin antagonist B4310 on smooth muscles and blood pressure in the rat, and its enzymatic degradation (1989) (20)
Neutral endopeptidase and alcohol consumption, experiments in neutral endopeptidase-deficient mice. (2000) (20)
Substance P immunoreactivity in the rat mammary nipple and the effects of capsaicin treatment on lactation (1984) (20)
Different behavioral profiles of the non-peptide substance P (NK1) antagonists CP-96,345 and RP 67580 in Swiss albino mice in the black-and-white box (1993) (19)
Neuropeptides in development and aging (1997) (19)
Inhibition of cigarette smoke-induced oedema in the nasal mucosa by capsaicin pretreatment and a substance P antagonist (1984) (19)
Tissue-specific depletion of NPY-like immunoreactivity by reserpine. (1985) (19)
Increased conditioned place preference for cocaine in high anxiety related behavior (HAB) mice is associated with an increased activation in the accumbens corridor (2014) (18)
What the clinician still has to be reminded of. (2004) (18)
Perinatal Use of Aripiprazole: Plasma Levels, Placental Transfer, and Child Outcome in 3 New Cases (2014) (18)
Phase 1A safety assessment of intravenous amitriptyline. (2007) (18)
Reacquisition of cocaine conditioned place preference and its inhibition by previous social interaction preferentially affect D1-medium spiny neurons in the accumbens corridor (2014) (18)
The Two Faces of Social Interaction Reward in Animal Models of Drug Dependence (2016) (17)
Effects of haloperidol, clozapine and citalopram on messenger RNA levels of chromogranins A and B and secretogranin II in various regions of rat brain (1995) (17)
[New aspects of the autonomic innervation of human nasal mucosa]. (1987) (16)
Comparable Sensitivities of Urine Cotinine and Breath Carbon Monoxide at Follow-Up Time Points of Three Months or More in a Smoking Cessation Trial (2010) (16)
Peripheral effects of opioid drugs on capsaicin-sensitive neurones of the guinea-pig bronchus and rabbit ear (1987) (16)
Release of histamine by neuropeptides from the perfused rat hindquarter (1983) (16)
Duloxetine plasma level and antidepressant response (2019) (16)
The impact of early environmental rearing condition on the discriminative stimulus effects and Fos expression induced by cocaine in adult male and female rats (2009) (16)
NGF but not GDNF or neurturin enhance acetylcholine tissue levels in striatal organotypic brain slices (1998) (15)
Beneficial effect of topically applied capsaicin in the treatment of hyperreactive rhinopathy (1988) (15)
Coexisting peptides in capsaicin-sensitive sensory neurons: release and actions in the respiratory tract of the guinea-pig. (1987) (14)
Social Interaction and Cocaine Conditioning in Mice Increase Spontaneous Spike Frequency in the Nucleus Accumbens or Septal Nuclei as Revealed by Multielectrode Array Recordings (2015) (14)
Calcitonin Gene—Related Peptide in the Brain (1992) (14)
[Treatment of nonspecific hyper-reflectory rhinopathy (vasomotor rhinitis) with capsaicin]. (1995) (13)
Release of secretoneurin and noradrenaline from hypothalamic slices and its differential inhibition by calcium channel blockers (1994) (13)
Different concentrations of vasoactive intestinal polypeptide in aqueous humor of patients with proliferative vitreoretinopathy and cataract patients. (1994) (13)
Retinoic acid treatment enhances the acetylcholine contents in the human teratocarcinoma cell line NTera-2 (2000) (12)
Behavioral and neurochemical changes after intracisternal capsaicin treatment of the guinea pig (1986) (12)
Capsaicin pretreatment inhibits heat-induced oedema in the rat skin (1983) (12)
Social interaction reward decreases p38 activation in the nucleus accumbens shell of rats (2015) (12)
Distribution of secretoneurin-like immunoreactivity in comparison with that of substance P in the human spinal cord (1995) (11)
[Peptidergic innervation of human salivary glands (parotid gland and submandibular gland)]. (1992) (11)
The role of substance P and other neuropeptides in transmission of pain. (1987) (11)
Ischaemia and changes in contractility induce release of calcitonin gene-related peptide but not neuropeptide Y from the isolated perfused guinea-pig heart. (1987) (11)
Elevated levels of substance P in intraocular fluid in proliferative vitreoretinopathy (1991) (11)
Obstructive Ileus of Large Bowel Is Associated with Low Tissue Levels of Neuropeptides in Prestenotic Bowel Segment (1997) (11)
Ontogenic development of secretogranin II and of its processing to secretoneurin in rat brain. (1997) (10)
Margatoxin increases dopamine release in rat striatum via voltage-gated K+ channels. (1998) (10)
Eicosapentaenoic acid inhibits vasoconstrictor- and noradrenaline-potentiating effects of neuropeptide Y in the isolated rabbit ear. (1988) (10)
Neuroimmune interactions in the airways: Implications for asthma, allergy, and other inflammatory airway diseases (1988) (10)
Activation of Sensory Substance P Neurones in the Respiratory Tract by Cigarette Smoke, Mechanical and Chemical Irritants (1984) (9)
Effects of GABA and l-glutamic acid on the potassium-evoked in vitro release of substance P- and neurokinin A-like immunoreactivities are different in the rat striatum and substantia nigra (1989) (9)
Secretoneurin, a novel neuropeptide, in the human dental pulp. (1998) (9)
Capsaicin pretreatment inhibits vagal cholinergic and non-cholinergic control of pulmonary mechanics in the guinea pig (1984) (9)
Neuropeptides with vascular activity: VIP, PHI, NPY and substance P. (1984) (9)
Voltage-gated, margatoxin-sensitive potassium channels, but not calcium-gated, iberiotoxin-sensitive potassium channels modulate acetylcholine release in rat striatal slices (1999) (8)
Peri‐Response Pharmacokinetics of Remifentanil during a Self‐Administration Session Indicates That Neither Blood nor Brain Levels Are Titrated (2006) (7)
Distribution of GABAAreceptor alpha 1 subunit‐like immunoreactivity in comparision with that of enkephalin and substance P in the rat forebrain (1995) (7)
Therapeutic drug monitoring-based clozapine dosing recommendations. (2007) (7)
Substance P: Characteristics of binding to synaptic vesicles of rat brain (2004) (7)
Margatoxin and iberiotoxin, two selective potassium channel inhibitors, induce c-fos like protein and mRNA in rat organotypic dorsal striatal slices (2000) (7)
The spinal cord contains multiple factors causing plasma protein extravasation in the skin. (1985) (7)
Phenyldiguanide and capsaicin stimulate functionally different populations of afferent C-fibers (1983) (7)
Regulatory peptides in the human larynx and recurrent nerves. (1993) (6)
Dose-related plasma levels of clozapine: influence of smoking, sex. and age (1989) (6)
Reinforcing effect of subcutaneous morphine in a modified ettenberg runway (2002) (6)
Indomethacin reduces substance P levels in human ocular aqueous humor. (1993) (6)
Differential increases of neurokinin B- and enkephalin-like immunoreactivities and their mRNAs after chronic haloperidol treatment in the rat (1992) (6)
Substance P: Model studies of its binding to phospholipids (1979) (6)
Definitions of a “Standard Drink” (2000) (6)
Different behavioral profiles of the non-peptide substance P (NK-1) antagonists CP-96,345 and RP 67580 (1993) (5)
Degradation of substance P, neurokinin A, and calcitonin gene-related peptide in rat plasma in vivo (1988) (5)
Lack of Reinforcing Effect of the Benzodiazepine and Tricyclic Antidepressant Combination of Diazepam and Dothiepin (2001) (5)
Effect of noradrenergic denervation by neonatal DSP-4 on peptide neurotransmitter systems in the rat brain (1992) (5)
Identification of α- and β-species of calcitonin gene-related peptide in the rat amygdala after separation with capillary zone electrophoresis (1992) (5)
Mesencephalic grafts increase preprotachykinin-A mRNA expression in striatal grafts in an in oculo co-graft model (1995) (5)
Drug History Overrides Opioid Reinforcement in a Rat Runway Procedure (2004) (5)
Effects of haloperidol and clozapine on preprotachykinin-A messenger RNA, tachykinin tissue levels, release and neurokinin-1 receptors in the striato-nigral system. (1990) (5)
Modulation of the release of tachykinins and calcitonin gene-related peptide from peripheral terminals of primary afferent neurons in the guinea-pig lung (1988) (5)
Increased synthesis of neurokinin B and enkephalin after chronic haloperidol treatment (1993) (4)
Complex allosteric interaction of heparin with neurokinin-1 receptors. (1991) (4)
Calcitonin gene-related peptide and fluid overload in congestive heart failure (1991) (4)
[Autonomic and peptidergic innervation of the human larynx]. (1994) (3)
The effect of nephrectomy and ureter ligation on plasma neurotensin-like immunoreactivity levels in the conscious rat. (1985) (3)
[Therapeutic drug monitoring in neuropsychopharmacology : Summary of the consensus guidelines 2017 of the TDM task force of the AGNP]. (2019) (3)
Allosteric Interaction of Heparin with NK‐1 Receptors in Rat Striatal Membranes (1991) (3)
Reserpine-induced depletion of neuropeptide Y from cardiovascular nerves and adrenal gland due to enhanced release (1986) (3)
Control of vascular permeability and vascular smooth muscle in the respiratory tract by multiple neuropeptides. (1989) (3)
Comparative distribution of neurokinin B (NKB), substance P (SP) and enkephalin in the basal forebrain of the rat: Evidence for neurochemical compartmentation (1992) (3)
Methadone Doses upon Multiple Readmissions to Inpatient Detoxification: Clinical Evidence for Very Moderate Opioid Tolerance (2006) (3)
Differential Changes in Tachykinins in the Rat Brain after Drug‐induced Seizures a (1991) (3)
Peptides and Transmission in Mammalian Sympathetic Ganglia and Spinal Cord (1987) (3)
Pharmacological Modulation of Antidromic Vasodilatation Measured by Laser Doppler Flowmetry (1987) (2)
Multiple Tachykinins and Calcitonin Gene-Related Peptide (CGRP) in Capsaicin-Sensitive Nerves of Sympathetic Ganglia (1987) (2)
Neurokinin‐1 Receptors in the Human Eye (1991) (2)
Calcitonin gene-related pedtide in the amygdaloid complex of the rat: Immunohistochemical and quantitative distribution, and drug effects on calcium-dependent, potassium-evokedin vitro release (1990) (2)
Regional distribution and biochemical properties of 125I-Tyr8-substance P binding sites in synaptic vesicles (1980) (2)
Retinal lesion by bright artificial light increases vasoactive intestinal polypeptide in the rat ventral tegmental area/substantia nigra (1991) (2)
Bronchial, cardiovascular and secretory responses after central administration of capsaicin in the guinea-pig (1986) (2)
Serum Aripiprazole Concentrations Prehemodialysis and Posthemodialysis in a Schizophrenic Patient With Chronic Renal Failure: A Case Report. (2020) (2)
Topical indomethacin decreases substance P immunoreactivity in human ocular aqueous humor (1993) (1)
Neurokinin-1 receptors in the human eye. Characterization and autoradiographic distribution. (1991) (1)
Modeling addiction: trusted experimental approaches are tried in new applications. (2002) (1)
DSM-IV and ICD-10 Definitions of Alcohol Intoxication, Abuse, Dependence, and Withdrawal (2000) (1)
Influence of milk on haloperidol pharmacokinetics. (1994) (1)
Positive correlation between substance P serum levels and pain threshold in ankylosing spondylitis (1993) (1)
[Changes in nasal volume flow following local administration of neuropeptide substance P and capsaicin]. (1987) (1)
“Neuropeptides 2000” 10th Annual Meeting of the European Neuropeptide Club, Innsbruck, Austria, May 10–13, 2000, Neuropeptide Antagonists, From Molecular Biology to Receptors and Clinical Applications, Supported by the European Commission DG XII, Human Potential Programme, High Level Scientific Conf (2000) (1)
Decreased substance P- and increased calcitonin gene-related peptide immunoreactivities in the cerebrospinal fluid of drug-naive schizophrenic patients (1991) (1)
The European Future Technologies Conference and Exhibition 2011 Introducing the Human Brain Project (2011) (1)
Obstructive ileus of the large bowel is associated with low tissue levels of neuropeptides in the prestenotic bowel segment (1995) (1)
Substance P and Synaptic Vesicles: Characteristics of Binding (1978) (1)
Agonist promiscuity: a positive twist. (1999) (1)
Lack of a distinctive behavioural effect of chromogranin-derived peptides in rodents (2002) (1)
Does pharmacology explain dosing adjustments during antipsychotic combination therapy under naturalistic clinical conditions (2011) (1)
Useful (Internet) Addresses (2000) (0)
Characterization, tissue distribution and biological activity of the novel neuropeptide secretoneurin (1994) (0)
The Practice of TDM in an Austrian University Hospital Setting: What the Clinician Still has to be Reminded of ... (2005) (0)
[Erratum to: Therapeutic drug monitoring in neuropsychopharmacology : Summary of the consensus guidelines 2017 of the TDM task force of the AGNP]. (2019) (0)
Differential responses of neurokinin A, neuropeptide Y and calcitonin gene-related peptide in kainic acid-induced epilepsy in the rat (1988) (0)
Erratum zu: Therapeutisches Drug-Monitoring in der Neuropsychopharmakologie (2019) (0)
Alcohol Contents of Typical Drinks (2000) (0)
B64 ACQUISITION OF OPIOID REINFORCEMENT IS PARALLELED BY AN INCREASE IN ACETYLCHOLINE BUT NOT DOPAMINE OVERFLOW IN THE NUCLEUS ACCUMBENS CORE (2005) (0)
Local effector function of ureteric afferents (1988) (0)
Contents Vol. 69, 2003 (2003) (0)
Invited speaker—Neuropeptides in schizophrenic disorder and their regulation by antipsychotic agents (1993) (0)
Organotypic Slices of Striatum and Mesostriatal Organotypic Co-Slices: Models for Analysis of Biochemistry and Function of Signaling Molecules. (1999) (0)
Contents Vol. 70, 2004 (2004) (0)
Author Index 9th APHAR Symposium (2003) (0)
Subject Index Vol. 70, 2004 (2004) (0)
Agonist promiscuity: A positive twist (multiple letters) [1] (1999) (0)
Secretoneurin and chromogranin a in human and bovine cerebrospinal fluid (1994) (0)
Section III: Useful Data and Definitions (2000) (0)
Subject Index Vol. 69, 2003 (2003) (0)
Harmful Daily Alcohol Consumption (2000) (0)
Prevalence of Lower-Than-Expected Plasma Levels in Medicated Patients Presenting for Acute Psychiatric Inpatient Treatment (2008) (0)
Concentrations of secretoneurin and chromogranin a immunoreactivities in the cerebrospinal fluid of schizophrenic patients (1995) (0)
Secretoneurin, a peptide derived from secretogranin II (chromogranin C), releases dopamine from rat striatal slices (1993) (0)
Neuropeptide tyrosine (NPY) inhibits PGE2-induced fluid and electrolyte secretion in the rat jejunum in vivo (1985) (0)
Identification of alpha- and beta-species of calcitonin gene-related peptide in the rat amygdala after separation with capillary zone electrophoresis. (1992) (0)
Regulatory peptides in insects, with special reference to the Australian cricket Teleogryllus commodus Walker (1988) (0)
Neurokinin-1 receptor-mediated inhibition of the release of endogenous dopamine from rat striatal slices (1992) (0)
Lecture Presentations L1 Microrna-target Interactions in Neurodegenerative Diseases Hermona Soreq Reacquisition of Cocaine Conditioned Place Preference and Its Inhibition by Previous Social Interaction: Neurochemical and Electrophysiological Correlates in the Nucleus Accumbens Corridor European Soci (0)
Tachykinins in Experimental Allergic Lung Disease (1997) (0)
Risperidone-treated Children and Adolescents with Behavioral Disorders: Do Drug Dose and Patients’ Gender and Age Relate to Drug and Metabolite Plasma Levels? (2017) (0)
Subject Index Vol. 72, 2004 (2004) (0)
Physicochemical Properties of Ethanol (2000) (0)
Neuropeptides in the human penis: An immunocytochemical and radioimmunological study (1992) (0)
Influence of patient-related variables on plasma levels of clozapine (1989) (0)
Contents Vol. 72, 2004 (2004) (0)
Preface (1997) (0)
The effect of indomethacin on substance P in human intraocular fluid (1992) (0)
Effects of chemical, electrolytical and surgical lesions on calcitonin gene-related peptide in the rat brain (1991) (0)
[Pharmacologic studies of cultivated human ciliated cells of the upper respiratory tract]. (1988) (0)
Straub phenomenon, locomotor impairment and sedation caused by (±)-CP-96,345 are not mediated via opioid receptors (1992) (0)
Alphabetical List of Psychometric Test Instruments (2000) (0)
Concomitant increase of neurokinin B- and enkephalin-like immunoreactivities and their mRNAs after chronic haloperidol (1992) (0)
St. John’s Wort (hypericum perforatum) and breastfeeding: concentrations of hyperforin in nursing infants and breast milk (2005) (0)
Functional and pharmacological aspects of neuropeptides: A conference report of the first meeting of the European Neuropeptide Club (1991) (0)
[A method of photometric measurement of the ciliary beat of cultivated ciliated cells of the upper respiratory tract in the human]. (1988) (0)
Unassisted Emergency Management of Acute Alcohol Intoxication (2000) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Alois Saria?

Alois Saria is affiliated with the following schools:

Medical University of Innsbruck
Karolinska Institute